Host microbiota and airway mucus: a novel paradigm for lung defense and immune homeostasis during early post-natal development
宿主微生物群和气道粘液:产后早期发育期间肺防御和免疫稳态的新范例
基本信息
- 批准号:10535465
- 负责人:
- 金额:$ 38.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAblationAdultAffectAgeAnimalsAntibiotic TherapyAntibioticsAsthmaBacterial InfectionsBacterial PneumoniaBiologyBronchoalveolar LavageCell Differentiation processCellsChildCongenic MiceCystic FibrosisDataDefense MechanismsDehydrationDevelopmentDiseaseElementsEpithelial CellsExhibitsGene ExpressionGerm-FreeHarvestHomeostasisHumanImmuneInfantInflammatoryInhalationKnockout MiceKnowledgeLifeLinkLungLung immune responseMUC5AC geneMediatingMessenger RNAModelingMucinsMucociliary ClearanceMucous body substanceMusNeonatalOperative Surgical ProceduresOrganOutcomePathogenesisPatternPerinatalPhenotypePredispositionProteinsPublicationsPulmonary Cystic FibrosisRNA, Ribosomal, 16SRecording of previous eventsRespiratory DiseaseRespiratory Signs and SymptomsRespiratory SystemSamplingSecretory CellShapesSignal TransductionSurfaceSyndromeSystemTestingTherapeuticTubeWild Type Mouseage relatedbiobankcongeniccystic fibrosis mousedysbiosisearly onsetendotrachealgerm free conditiongut dysbiosisgut microbiotagut-lung axishistological specimenshost microbiomehost microbiotainterleukin-22lung healthlung microbiotamRNA ExpressionmRNA sequencingmucus clearancemucus-associated lung diseasesneonatal miceneonatal periodneonatenovelpediatric patientspostnatalpostnatal developmentpostnatal periodprotein expressionrRNA Genestranscriptome
项目摘要
Airway mucus clearance is a primary lung defense mechanism and the early neonatal period
represents a critical “window of susceptibility” for lung health. Perinatal changes in key components of the
mucus clearance system have been qualitatively described, but the details and functional significance of these
changes are unknown. Our preliminary data in mice and humans indicate that: 1) airway mucus composition is
developmentally regulated; and 2) components of the mucus clearance system are affected by the status of
the host microbiota in early life. We have identified a testable mechanism to link the host microbiota with
neonatal airway mucus biology and lung homeostasis, i.e., the IL-22+ILC3-mediated gut-lung axis. We also
posit that humans exhibit age-dependent changes in key elements contributing to airway mucus clearance,
e.g., MUC5AC levels. To test these hypotheses, we propose the following aims: 1) To test whether host
microbiota dysbiosis or blockade of the IL-22+ILC3-mediated gut-lung axis affect the abundance,
composition, and function of airway mucus in neonatal vs. adult mice. Congenic mice raised in germ-free
or specific-pathogen free conditions, either naïve or treated with antibiotics, will be assessed at post natal day
(PND)10 and PND66 for: 1) bronchoalveolar lavage (BAL) protein composition, mucus concentration, and
secreted mucins quantification; 2) airway mucociliary clearance; and 3) lung mRNA sequencing. Specific
contributions of IL-22 signaling and outcomes in the context of airway surface dehydration will be assessed
using IL-22 KO mice and Scnn1b-Tg mice, respectively. Changes in host microbiota will be determined by
bacterial 16S ribosomal RNA gene quantification. 2) To test whether CF-like host microbiota dysbiosis
affects the establishment of the normal, IL-22+ILC3-mediated gut-lung axis in neonatal mice. Congenic
∆F508 CF mice and WT littermates, either naïve or treated with antibiotics, will be used at PND10 to study the
influx of IL22+ILC3 cells into the lung referenced to quantitative analysis of their gut microbiota. In parallel, lung
and BAL samples will be collected to assess the effect of CF gut dysbiosis on the early lung transcriptome and
the composition of neonatal airway secretions. Crosses with Scnn1b-Tg mice will be used to exacerbate the
∆F508 CF lung phenotype. 3) To test whether the composition of “healthy” airway mucus presents age-
dependent, quantitative differences in humans. Airway mucus samples harvested from endotracheal tubes
used in neonates/infants/children (0-5 years old) and adults (25-40 years old) with no history or symptoms of
respiratory diseases will be analyzed for mucin and protein composition. Histologic specimens obtained from
the LungMAP
Biorepository (BRINDL)
will be probed for mRNA and protein expression of specific mucus
markers. Completion of these aims will establish a new conceptual framework and provide much needed
experimental evidence to study the pathogenesis, develop therapeutic approaches, and account for host
microbiota influences on “early” lung health and early onset muco-obstructive lung diseases.
气道粘液清除是新生儿早期肺部防御的主要机制
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alessandra Maria Livraghi-Butrico其他文献
Alessandra Maria Livraghi-Butrico的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alessandra Maria Livraghi-Butrico', 18)}}的其他基金
Host microbiota and airway mucus: a novel paradigm for lung defense and immune homeostasis during early post-natal development
宿主微生物群和气道粘液:产后早期发育期间肺防御和免疫稳态的新范例
- 批准号:
10305691 - 财政年份:2020
- 资助金额:
$ 38.88万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant